Claudia Colaiacomo | Ingegneria Tissutale | Young Researcher Award

Dr. Claudia Colaiacomo | Ingegneria Tissutale | Young Researcher Award

Ph.D. student at Campus Bio-Medico University of Rome, Italy

Claudia Colaiacomo is a biomedical engineer and emerging researcher whose academic and professional journey reflects her strong commitment to advancing biomedical sciences, regenerative medicine, and biomedical technologies. With a foundation in engineering principles and a deep interest in the intersection of medicine and innovation, she has cultivated expertise in tissue engineering, nanotechnology, and bioethics. Her work integrates technical rigor with translational potential, making her a promising contributor to the global biomedical research community.

Professional Profile

Scopus Profile | ORCID

Education

Claudia began her academic training with a degree in Medical Engineering from the University of Rome Tor Vergata, where she built a solid base in biomedical instrumentation, nanomedicine, and healthcare technologies. Her thesis explored hydrogel-based approaches for corneal blindness, highlighting her early interest in biomaterials and regenerative solutions. She then pursued a Master’s degree in Biomedical Engineering at the Campus Bio-Medico University of Rome, specializing in Nanotechnologies and Bioartificial Systems. Her master’s thesis, titled “Aromatic-Decorated Nanogels: Synthesis and Evaluation of Cell Uptake under Static and Dynamic Conditions”, was developed within the Tissue Engineering and Chemistry for Engineering Laboratory. The research advanced knowledge of nanogels for drug delivery and biomedical applications, combining microfabrication techniques with cell culture models. Building on her academic accomplishments, Claudia embarked on doctoral studies in Biomedical Sciences and Bioethics, focusing on the science of ageing and tissue regeneration. Her Ph.D. research reflects her interdisciplinary outlook, merging biomedical engineering with ethical considerations of regenerative medicine.

Experience

Claudia’s professional career is closely tied to the Campus Bio-Medico University of Rome, where she has served as a research fellow and collaborator in the Laboratory of Regenerative Orthopedics and Traumatology. She has contributed to multiple funded projects, including initiatives on artificial intelligence applications for risk assessment and prevention of low back pain. In this role, she demonstrated expertise in scientific reporting, data analysis, team management, and the development of scientific presentations. Her technical skills include advanced laboratory methods such as cell culture, 3D culture models, RT-PCR, Western blotting, flow cytometry, and confocal microscopy. In parallel, she has served as a personal tutor for undergraduate engineering students, supporting their academic and organizational development. Claudia’s early experiences also include research internships in tissue engineering and clinical collaborations, which allowed her to combine laboratory innovation with applied medical perspectives.

Research Focus

Claudia’s research focus lies at the interface of regenerative medicine, biomedical nanotechnology, and computational innovation. She is particularly interested in the regenerative potential of bioengineered systems, extracellular vesicles, and nanomaterials for therapeutic use. Her doctoral work expands into the science of ageing and tissue repair, aiming to develop strategies that promote musculoskeletal health and resilience in ageing populations. Furthermore, her engagement with artificial intelligence-based precision spine care highlights her ability to bridge engineering solutions with clinical applications. Claudia’s academic projects further underscore her breadth of interest, ranging from the design of stabilizing devices for Parkinson’s patients to computational models of vascular stent behavior and robotic systems for biomedical applications.

Publication Top Notes

Title: Existence of One Solution to a Complete Second Order Discrete Problem of Neural Type with Possibly Negative Coefficients
Authors: Eleonora Amoroso; Claudia Colaiacomo; Giuseppina D’Aguì; Pierandrea Vergallo
Summary: This article establishes the existence of solutions for second-order discrete neural problems with negative coefficients, contributing to mathematical modeling of complex neural dynamic systems.

Title: Whole-Body Electromyostimulation Coupled with Aerobic Exercise Boosts Serum Irisin Levels in Healthy Individuals: A Pilot Study
Authors: Claudia Colaiacomo
Summary: This pilot study demonstrates that combining whole-body electromyostimulation with aerobic exercise significantly enhances serum irisin levels, indicating potential for improved metabolic health interventions.

Title: A Second Order Hamiltonian Neural Model
Authors: Eleonora Amoroso; Claudia Colaiacomo; Giuseppina D’Aguì; Pierandrea Vergallo
Summary: The study develops a second-order Hamiltonian model for neural systems, offering mathematical insights into neuronal dynamics and advancing theoretical approaches in applied mathematics and neuroscience.

Conclusion

Claudia Colaiacomo represents a new generation of biomedical engineers and researchers whose work embodies both innovation and impact. Her educational path, combining medical engineering, biomedical nanotechnology, and regenerative sciences, provides her with the versatility to approach complex healthcare challenges. Through her professional experience, she has demonstrated leadership, technical mastery, and the capacity to integrate experimental and computational methods. Her research focus on tissue regeneration, ageing, and translational therapies addresses pressing global health challenges, while her publications underscore her interdisciplinary collaborations and scientific contributions. Claudia’s dedication to merging engineering, medicine, and ethics positions her as a strong candidate for recognition in biomedical research. She exemplifies the qualities of an award nominee by combining academic excellence, professional engagement, and a clear vision for advancing healthcare through innovation.

Eyachew Misganew Tegaw | Cancer | Best Researcher Award

Assist. Prof. Dr. Eyachew Misganew Tegaw | Cancer | Best Researcher Award

Assistant Professor of Medical Physics, Debre Tabor University, Ethiopia

Dr. Eyachew Misganew Tegaw is an Assistant Professor at Debre Tabor University, Ethiopia, specializing in Medical Physics. He earned his PhD from Tehran University of Medical Sciences, focusing on enhancing intraoperative radiotherapy for breast cancer using nanoparticles. With a robust background in condensed matter and applied physics, Dr. Tegaw has contributed significantly to radiotherapy, dosimetry, and medical imaging research. His work integrates advanced computational methods, including Monte Carlo simulations and machine learning, to improve cancer treatment outcomes. Dr. Tegaw’s dedication to academia and research has positioned him as a leading figure in medical physics, with numerous publications and collaborations that underscore his commitment to advancing cancer therapy.

Professional Profile

Education

Dr. Eyachew Misganew Tegaw’s academic journey began with a BSc in Applied Physics from the University of Gondar, Ethiopia. He then pursued an MSc in Condensed Matter Physics at Mekelle University, where he conducted a theoretical study on gold-coated iron nanoparticles for medical applications. His academic pursuits culminated in a PhD in Medical Physics from Tehran University of Medical Sciences, Iran. His doctoral research focused on enhancing intraoperative radiotherapy for breast cancer using effective nanoparticles, under the guidance of esteemed supervisors and advisors. Throughout his education, Dr. Tegaw has undertaken comprehensive coursework in areas such as radiobiology, radiation protection, imaging techniques, and computational physics, laying a strong foundation for his research endeavors in medical physics.

Experience 

Dr. Eyachew Misganew Tegaw has amassed extensive experience in academia and research. He began his career as a Lecturer in the Department of Physics at Debre Tabor University, Ethiopia, where he served from April 2011 to August 2016. Following his doctoral studies, he resumed his role at the university as an Assistant Professor in October 2020. In addition to teaching, Dr. Tegaw has held leadership positions, including Head of the Physics Department and Chairman of the Ethiopian Space Science Society’s Debre Tabor branch. His responsibilities have encompassed curriculum development, research supervision, and organizing workshops aimed at enhancing educational quality and research output. Dr. Tegaw’s commitment to education and research has significantly contributed to the advancement of medical physics in Ethiopia.

Research Focus 

Dr. Eyachew Misganew Tegaw’s research centers on advancing cancer treatment through medical physics. His primary focus areas include radiotherapy techniques such as 3D-CRT, IMRT, VMAT, and IORT, with a particular interest in dose enhancement using nanoparticles. He employs Monte Carlo simulations to model radiation interactions and optimize treatment planning. Dr. Tegaw also explores the integration of artificial intelligence and machine learning to predict treatment outcomes and personalize therapy. His interdisciplinary approach extends to imaging modalities like CT, MRI, and nuclear medicine, aiming to improve diagnostic accuracy and treatment efficacy. Through his research, Dr. Tegaw seeks to bridge the gap between theoretical physics and clinical applications, contributing to the development of more effective and safer cancer therapies.

Publication Top Notes

  1. Explainable Machine Learning to Compare the Overall Survival Status Between Patients Receiving Mastectomy and Breast Conserving Surgeries

    • Authors: Betelhem Bizuneh Asfaw, Eyachew Misganew Tegaw

    • Published: March 2025

    • Journal: Scientific Reports

    • Summary: This study utilizes explainable machine learning techniques to compare survival outcomes between breast cancer patients undergoing mastectomy versus breast-conserving surgery, providing insights into treatment efficacy.

  2. Explainable Machine Learning and Feature Interpretation to Predict Survival Outcomes in the Treatment of Lung Cancer

    • Authors: Eyachew Misganew Tegaw, Betelhem Bizuneh Asfaw

    • Published: May 2025

    • Journal: Seminars in Oncology

    • Summary: The research applies explainable machine learning models to predict survival outcomes in lung cancer treatment, highlighting key biomarkers influencing patient prognosis.

  3. Attenuation Correction for Dedicated Cardiac SPECT Imaging Without Using Transmission Data

    • Authors: Getu Tadesse, Parham Geramifar, Mehrshad Abbasi, Eyachew Misganew Tegaw, et al.

    • Published: February 2023

    • Journal: Molecular Imaging and Radionuclide Therapy

    • Summary: This study proposes a method for attenuation correction in cardiac SPECT imaging without relying on transmission data, enhancing image quality and diagnostic accuracy.

  4. Diagnostic Performance of Mammography and Ultrasound in Breast Cancer: A Systematic Review and Meta-Analysis

    • Authors: Getu Tadesse, Eyachew Misganew Tegaw, Ejigu Kebede Abdisa

    • Published: January 2023

    • Journal: Journal of Ultrasound

    • Summary: The meta-analysis evaluates the diagnostic accuracy of mammography and ultrasound in breast cancer detection, providing evidence-based recommendations for clinical practice.

  5. Gold-Nanoparticle-Enriched Breast Tissue in Breast Cancer Treatment Using the INTRABEAM® System: A Monte Carlo Study

    • Authors: Eyachew Misganew Tegaw, Ghazale Geraily, Somayeh Gholami, Mehdi Shojaei, Getu Tadesse

    • Published: March 2022

    • Journal: Radiation and Environmental Biophysics

    • Summary: This research investigates the use of gold nanoparticles to enhance the efficacy of intraoperative radiotherapy in breast cancer treatment, utilizing Monte Carlo simulations for dose distribution analysis.

  6. Comparison of Organs at Risk Doses Between Deep Inspiration Breath-Hold and Free-Breathing Techniques During Radiotherapy of Left-Sided Breast Cancer: A Meta-Analysis

    • Authors: Eyachew Misganew Tegaw, Getu Tadesse, Ghazale Geraily, Somayeh Gholami, Wondesen Tassew Gebreamlak

    • Published: March 2022

    • Journal: Polish Journal of Medical Physics and Engineering

    • Summary: The study compares radiation doses to critical organs using deep inspiration breath-hold versus free-breathing techniques in left-sided breast cancer radiotherapy, highlighting the benefits of breath-hold methods.

  7. Dosimetric Effect of Nanoparticles in the Breast Cancer Treatment Using INTRABEAM® System with Spherical Applicators in the Presence of Tissue Heterogeneities: A Monte Carlo Study

    • Authors: Eyachew Misganew Tegaw, Ghazale Geraily, Seyed Mohsen Etesami, Hossein Ghanbari, Somayeh Gholami, Mehdi Shojaei, Mostafa Farzin, Getu Tadesse

    • Published: April 2021

    • Journal: Biomedical Physics & Engineering Express

    • Summary: This study evaluates the impact of tissue heterogeneities on dose distribution when using nanoparticles in intraoperative radiotherapy for breast cancer, employing Monte Carlo simulations for analysis.

  8. A Comparison Between EGSnrc/Epp and MCNP Monte Carlo Codes in Simulation of the INTRABEAM® System with Spherical Applicators

    • Authors: Eyachew Misganew Tegaw, Ghazale Geraily, Seyed Mohsen Etesami, Somayeh Gholami, Hossein Ghanbari, Mostafa Farzin, Getu Tadesse, Mehdi Shojaei

    • Published: January 2021

    • Journal: Journal of Biomedical Physics & Engineering

    • Summary: The research compares two Monte Carlo simulation codes, EGSnrc/Epp and MCNP, in modeling the INTRABEAM® system for breast cancer treatment, assessing their accuracy and computational efficiency.

Conclusion

Dr. Eyachew Misganew Tegaw stands out as a promising and innovative researcher in the field of medical physics and oncology technology. His diverse yet focused expertise, combined with his growing publication record, interdisciplinary approaches, and contribution to science leadership in Ethiopia, strongly support his nomination for a Best Researcher Award.

Emily Sabo | Biochemistry | Best Researcher Award

Dr. Emily Sabo | Biochemistry | Best Researcher Award

Previous Student, Colorado School of Mines, United States

Dr. E.T. Sabo is a graduate student at Colorado School of Mines, pursuing a Ph.D. in Applied Chemistry under the mentorship of Dr. Richard Holz. Their research focuses on the sulfur mobilization mechanisms for Fe-S cluster biosynthesis in Staphylococcus aureus, aiming to uncover critical insights into bacterial biochemistry and potential antibiotic targets. With a solid background in chemical and biochemical techniques, Dr. Sabo has developed expertise in protein purification, enzyme kinetics, crystallography, and computational modeling. Throughout their career, they have mentored undergraduate and high school students, participated in outreach programs, and contributed to community-building efforts within the academic environment. With multiple publications and presentations in leading journals and conferences, Dr. Sabo is recognized for their scientific acumen, leadership, and passion for advancing biochemistry.

Profile

Education

Dr. E.T. Sabo is currently completing a Ph.D. in Applied Chemistry at Colorado School of Mines (Aug 2019–Dec 2024), under the supervision of Dr. Richard Holz. Their dissertation explores the sulfur mobilization mechanisms for Fe-S cluster biosynthesis in Staphylococcus aureus, an area of great interest for antimicrobial research. Prior to their graduate studies, Dr. Sabo earned a B.S. in Chemistry with a minor in Mathematics from the University of Georgia (Aug 2015–May 2019). This foundational training set the stage for their extensive work in biochemistry and molecular biology, equipping them with a deep understanding of both chemical and biological systems. The combination of rigorous academic training and hands-on research experience allows Dr. Sabo to bridge the gap between theoretical chemistry and practical laboratory applications in their work on sulfur biochemistry and enzyme function.

Experience

Dr. Sabo’s research experience includes a diverse set of skills in applied chemistry and biochemistry. As a Graduate Research Assistant at Colorado School of Mines (2020–2024), Dr. Sabo focused on studying sulfur mobilization in bacterial enzymes, such as cysteine desulfurases. This involved advanced techniques such as protein purification, enzyme kinetics, protein crystallography, and computational docking. Notably, they developed assays for high-throughput screening (HTS) to study enzyme inhibition and optimized crystallography screens for structural analysis. Additionally, Dr. Sabo has significant experience with UV-Vis and EPR spectroscopy and molecular modeling, crucial tools in biochemistry research. Their undergraduate experience at the University of Georgia (2015–2019) also involved working on mass spectrometry-based analyses of glycan metabolites in human kidney cells, further strengthening their broad skillset. Dr. Sabo has consistently demonstrated an ability to mentor and collaborate with students, as well as present complex research findings at conferences.

Awards and Honors

Dr. E.T. Sabo has earned several accolades recognizing their outstanding contributions to research and academics. They received the Mines GRADS Best Oral Talk award in March 2024, securing 2nd place in Biological, Health, and Social Sciences. Their work was recognized for its depth and clarity in communicating complex scientific concepts. Dr. Sabo also received the prestigious ACS travel award in August 2022, facilitating their participation in the American Chemical Society’s Division of Inorganic Chemistry conference. As an undergraduate, Dr. Sabo was awarded the Classic Scholar Award at the University of Georgia, which acknowledged their academic excellence. Their dedication to advancing scientific understanding and contributing to the academic community has been instrumental in the recognition they’ve received. These honors highlight Dr. Sabo’s growing reputation as an emerging leader in the field of applied chemistry and biochemistry, especially in the study of bacterial biochemistry.

Research Focus

Dr. E.T. Sabo’s research is focused on understanding sulfur mobilization mechanisms for Fe-S cluster biosynthesis in Staphylococcus aureus, a critical process for bacterial survival and virulence. By studying the cysteine desulfurase complex in this pathogenic bacterium, Dr. Sabo aims to uncover potential targets for novel antimicrobial therapies. Their work delves into enzyme kinetics, protein-protein interactions, and the structural characterization of sulfur transfer pathways, with the goal of improving our understanding of microbial biochemistry. The research also extends to the study of small molecule inhibitors and their effect on sulfur metabolism, which could offer insights into the development of new antibiotic strategies. Additionally, Dr. Sabo is exploring computational approaches to model protein-ligand interactions, further enhancing the ability to predict and design compounds that interfere with sulfur cluster biosynthesis. This interdisciplinary approach promises to advance both basic biochemistry and applied pharmaceutical research.

Publications

  1. Boncella, A. E.; Sabo, E. T.; Santore, R. M.; Carter, J.; Whalen; Hudspeth, J. D.; Morrison, C. N. “The expanding utility of iron-sulfur clusters: Their functional roles in biology, synthetic small molecules, maquettes and artificial proteins, biomimetic materials, and therapeutic strategies.” Coordination Chemistry Reviews, 453, 2022. 🔬⚛️
  2. Hudspeth, J.D.; Boncella, A. E.; Sabo, E. T.; Andrews, T.; Boyd, J.; Morrison, C.N. “Structural and Biochemical Characterization of the Cysteine Desulfurase Complex SufSU.” ACS Omega, 7(48), 44124-44133, 2022. 🧬🧪
  3. Sabo, E.T. and Nelson, C.; Stark, V.; Aasman, K.; Boyd, J.; Holz, R. “Practical Spectrophotometric Assay for the Cysteine Desulfurase SufS from Staphylococcus aureus, a Potential Antibiotic Target.” Antibiotics. Accepted. 💊🦠
  4. Sabo, E.T.; Gerlich, G.; Nelson, C.; Stark, V.; Aasman, K.; Morrison, C.; Boyd, J.; Holz, R. “Kinetic Analysis of Cysteine Desulfurase SaSufS from Staphylococcus aureus.” In preparation. 🧑‍🔬🔎
  5. Sabo, E.T., Nelson, C.; Bennet, B.; Holz, R. “Cobalt Substitution of the Zinc-dependent Sulfur Transferase SaSufU from Staphylococcus aureus.” In preparation. ⚙️💡

 

 

Uday Muddapur | Environmental and Biomedical | Outstanding Scientist Award

Dr. Uday Muddapur | Environmental and Biomedical | Outstanding Scientist Award

Professor,KLE Technological Univeristy,India

Dr. Uday M. Muddapur’s curriculum vitae reflects an accomplished academic and research profile in the field of biotechnology and biochemistry. As a Professor in the Department of Biotechnology at KLE Technological University, Hubballi, he holds a Ph.D. in Biochemistry from the Department for Postgraduate Studies in Biochemistry at Karnatak University, Dharwad. His doctoral research focused on fungal transformation of Δ3-Carene, fungal amylase, and fungal pigments.

Profile:

Academic Qualifications:

  • Ph.D. in Biochemistry, Karnatak University, Dharwad, 2004.
  • M.Sc. in Biochemistry, Karnatak University, Dharwad, 1999.

Research and Fellowship:

  • Dr. Muddapur has guided several doctoral students, focusing on areas such as drug designing for tuberculosis, biosynthesis of nanoparticles, and evaluation of biomarkers for diseases like lymphatic filariasis.
  • He has been awarded multiple research honors, including “Project of the Year” by KSCST and the “Outstanding Scientist Award” at the INSO International Scientist Awards in 2022.

Teaching and Online Education:

  • Dr. Muddapur has taught subjects such as Biochemistry, Microbiology, Enzyme Technology, and Biotechnology. Additionally, he has completed several online courses related to biochemical energy metabolism, drug discovery, immunology, and bioinformatics.

Research Interests:

His research interests lie in areas such as:

  • Drug discovery and development.
  • Nanotechnology applications, including the synthesis and characterization of nanoparticles.
  • Microbial biotechnology and bioremediation.
  • Biomedical applications of bioactive compounds.

Publications:

Dr. Muddapur has authored multiple journal articles in reputable scientific publications. Some of his recent works include studies on the biomedical uses of phytochemicals, antimicrobial properties of nanoparticles, and the bioremediation of plastics by fungi.

Professional Links:

  • ORCID: 0000-0003-3463-1989
  • Scopus ID: 55773089600
  • Google Scholar ID: Zwn4E-kAAAAJ

Previous Positions:

  • Professor at KLE Technological University, Hubballi (since 2016).
  • Professor at KLE Society’s College of Engineering and Technology, Belgaum (2005-2016).
  • Lecturer at Pooja Bhagavat Memorial Mahajana Post Graduate Centre, Mysore (2004-2005).

Dr. Muddapur’s work spans diverse areas of biochemistry and biotechnology, with a significant contribution to research and academia, especially in bioactive compound development and nanomedicine.

Xiaoting Peng | Bio-Medical Materials and Engineering | Best Researcher Award

Dr. Xiaoting Peng | Bio-Medical Materials and Engineering | Best Researcher Award

Postdoctor, University of Health and Rehabilitation Sciences, China

Dr. Peng Xiaoting is a dedicated postdoctoral researcher at the University of Health and Rehabilitation Sciences, specializing in the development of advanced biomaterials. Her research focuses on creating innovative biomaterials with unique chemical, physical, and biological properties, aimed at improving the diagnosis and treatment of complex diseases such as cancer, tissue injury, and defects. Dr. Peng’s groundbreaking work in the field of biomedical engineering is paving the way for personalized and effective therapies. Her research interests span materials engineering, biomedical engineering, materials chemistry, and nanotechnology, with a commitment to translating laboratory findings into clinical applications. With numerous publications in high-impact journals, she is recognized for her contributions to advancing biomedical science. Dr. Peng is passionate about improving patient outcomes and enhancing tissue repair through novel biomaterials-based strategies.

Profile

Google Scholar

Education

Dr. Peng Xiaoting holds an advanced academic background in materials engineering and biomedical sciences. She completed her undergraduate and graduate education in China, where she earned her Bachelor’s and Master’s degrees in Materials Science. Building on her foundational studies, she pursued a Ph.D. in Biomedical Engineering, focusing on the synthesis and application of biomaterials for medical use, particularly in cancer treatment and tissue regeneration. Throughout her academic career, Dr. Peng has collaborated with leading researchers in the fields of materials chemistry and nanotechnology, enhancing her interdisciplinary knowledge and expertise. Her education has provided her with a deep understanding of material properties at the molecular level, which she applies to the development of innovative biomedical solutions. She continues to build on this knowledge in her current postdoctoral research role, where she is involved in cutting-edge projects aimed at solving complex medical challenges using advanced biomaterials.

Experience

Dr. Peng Xiaoting has extensive experience in both academic research and practical applications of biomaterials in the biomedical field. As a postdoctoral researcher at the University of Health and Rehabilitation Sciences, she focuses on developing advanced biomaterials with applications in cancer treatment, tissue repair, and regeneration. She is involved in several ongoing projects, including those funded by the Qingdao Natural Science Foundation, demonstrating her ability to secure competitive research grants. Dr. Peng has published extensively in renowned scientific journals, contributing significantly to the understanding of self-assembly peptide-based materials and their potential for medical applications. Her research experience spans materials engineering, biomedical engineering, materials chemistry, and nanotechnology. Prior to her postdoctoral work, Dr. Peng gained experience in both laboratory-based research and theoretical study, allowing her to tackle real-world challenges in the field of biomedicine. She remains committed to advancing the translation of scientific discoveries into clinical therapies.

Research Focus

Dr. Peng Xiaoting’s research focuses on the development and application of advanced biomaterials for the diagnosis and treatment of complex diseases such as cancer, tissue injuries, and defects. She specializes in designing and synthesizing biomaterials that possess unique chemical, physical, and biological properties. Her work aims to bridge the gap between laboratory research and clinical applications by developing materials that can be utilized for tissue regeneration, drug delivery systems, and cancer therapy. Dr. Peng is particularly interested in self-assembly peptide-based materials, exploring their potential in stimulating tissue repair and enhancing therapeutic efficacy. Her expertise spans several interdisciplinary fields, including materials engineering, biomedical engineering, nanotechnology, and materials chemistry. Through her research, Dr. Peng seeks to push the boundaries of biomedical science and improve patient outcomes, particularly by advancing personalized and effective treatment strategies using novel biomaterials. Her ultimate goal is to contribute to the clinical translation of innovative biomaterials-based strategies.

Publication Top Notes

  1. Rapid Hemostasis Resulting from the Synergism of Self-Assembling Short Peptide and O-Carboxymethyl Chitosan 🩸🧬
  2. Modulation of antimicrobial peptide conformation and aggregation by terminal lipidation and surfactants 💊🧫
  3. Evaluation of a photocrosslinkable hydroxyethyl chitosan hydrogel as a potential drug release system for glaucoma surgery 👁️💉
  4. Catechol-stimulated crosslinking of catechol-conjugated hydroxyethyl chitosan as a tissue adhesive 🧪🩹
  5. Effects of conventional surfactants on the activity of designed antimicrobial peptide 🧴🦠
  6. Amyloid-like aggregates of short self-assembly peptide selectively induce melanoma cell apoptosis 🧬💀
  7. Chitosan as a tissue adhesive 💡🦠
  8. Catechol-conjugated hydroxyethyl chitosan as a tissue adhesive 🔬🩻

Jorge Amador Berlanga-Acosta | Medicine and Health Sciences | Best Researcher Award

Prof Dr Jorge Amador Berlanga-Acosta | Medicine and Health Sciences | Best Researcher Award

Research project leader, Center for Genetic Engineering and Biotechnology, Cuba

Dr. Jorge Amador Berlanga Acosta is a distinguished Cuban veterinary medicine and pharmaceutical scientist, born on October 11, 1962, in Bayamo, Granma, Cuba. With a career spanning over three decades, he specializes in the pharmacological applications of Epidermal Growth Factor (EGF) for wound healing and diabetic foot ulcers. He holds several prestigious titles, including Member of Honor of the Cuban National Academy of Science and Distinguished Professor at the University of Electronic Science and Technology of China. Dr. Berlanga has made significant contributions to biomedical research and has been instrumental in various clinical trials and technical missions across multiple continents, earning recognition for his impactful work in regenerative medicine and pharmacology. His expertise is complemented by a strong commitment to education and mentorship in the scientific community. 🌟

Profile

Google Scholar

Strengths for the Award

  1. Extensive Education and Training: Dr. Berlanga has a solid academic background with a Doctor of Veterinary Medicine and a Ph.D. in Pharmaceutical Sciences and Pharmacology. His post-doctoral fellowships at prestigious institutions like the University of Alberta and Imperial Cancer Research Fund highlight his commitment to advancing medical knowledge.
  2. Research Contributions: His extensive work on epidermal growth factor (EGF) and its applications in wound healing, particularly in diabetic foot ulcers, is groundbreaking. He has led numerous research projects and has a substantial number of publications in reputable journals, indicating his active engagement in critical biomedical research.
  3. Recognition and Awards: Dr. Berlanga has received numerous prestigious awards, including the “Héroe del Trabajo de la República de Cuba” and various international recognitions, showcasing his impact and contributions to the field.
  4. Leadership in Scientific Community: His roles in coordinating research commissions, leading projects, and serving as a speaker at over 40 international conferences illustrate his leadership and influence in the scientific community.
  5. Multidisciplinary Approach: His research spans various aspects of pharmacology, tissue repair, and regenerative medicine, demonstrating his ability to integrate knowledge across disciplines effectively.
  6. International Collaboration: Dr. Berlanga’s involvement in international workshops and conferences shows his commitment to collaboration and the dissemination of knowledge globally.

Areas for Improvement

  1. Broader Research Scope: While Dr. Berlanga’s focus on EGF is significant, exploring additional areas of research could enhance his impact. Diversifying his research portfolio may lead to novel insights and applications in other fields of medicine.
  2. Public Engagement and Communication: Increasing his outreach efforts to communicate research findings to the general public could enhance the visibility of his work and its implications for healthcare.
  3. Mentorship Opportunities: Engaging more with younger researchers and students through mentorship programs could foster the next generation of scientists and broaden the research community’s perspectives.
  4. Interdisciplinary Collaboration: Further collaboration with other scientific disciplines, such as engineering or technology, could lead to innovative approaches in his research areas.

Education

Dr. Berlanga’s educational journey began with primary education in Bayamo, Granma, followed by secondary schooling. He obtained his Doctor of Veterinary Medicine from the Universidad de Granma in 1985. He furthered his studies with a PhD in Pharmaceutical Sciences and Pharmacology from the Universidad de La Habana in 2000. His academic pursuits included post-doctoral fellowships at renowned institutions, such as the University of Alberta in Canada and the Leicester General Hospital in the UK, focusing on wound healing and gastroenterology. Additionally, he completed numerous specialization courses in clinical pathology, molecular biology, and experimental pharmacology. His diverse educational background has equipped him with the knowledge and skills to advance biomedical research and contribute to the field significantly. 🎓

Experience

Dr. Berlanga’s professional experience includes roles as an instructor and assistant lecturer in Anatomical Pathology at the Universidad de Granma and as an Associate Professor of Pathology. He has been a researcher at the Centro de Ingeniería Genética y Biotecnología (CIGB) in Havana, focusing on EGF’s pharmacological effects and wound healing mechanisms. Over the years, he has led various departments and projects within CIGB, including preclinical studies and diabetic foot ulcer healing initiatives. His leadership has driven significant advancements in understanding tissue repair and regeneration. In addition to his research, Dr. Berlanga has been a prominent speaker at numerous international conferences, sharing his findings and fostering collaboration in the scientific community. His extensive experience has established him as a leading figure in the field of biomedical sciences. 🔬

Awards and Honors

Dr. Berlanga’s contributions to science have earned him numerous accolades. He received the Alberta Heritage Foundation Scholarship in 1995 and the Royal Society Annual Award in 1998. In 2011, he was honored with the Distinción Carlos J. Finlay and recognized by the World Intellectual Property Organization as the best young inventor. His achievements include being named Hijo Ilustre de Granma and Bayamo, as well as receiving the prestigious title of Héroe del Trabajo de la República de Cuba in 2020. He has also been acknowledged as a Distinguished Professor at the University of Electronic Science and Technology of China. These awards highlight his significant impact on science and society through innovative research and dedication to education. 🏆

Research Focus

Dr. Berlanga’s research primarily focuses on the pharmacological applications of Epidermal Growth Factor (EGF) in wound healing and tissue regeneration. His investigations have led to the development of various animal models to study EGF’s effects on diabetic foot ulcers, ischemia/reperfusion injury, and gastrointestinal health. He explores the molecular mechanisms underlying EGF’s protective properties and its role in enhancing healing processes. His work also includes studying cellular pathologic memory and its implications in diabetes and wound chronicity. Dr. Berlanga’s commitment to advancing regenerative medicine continues to shape therapeutic strategies for complex wound healing challenges, making significant contributions to biomedical science. 🧬

Publication Top Notes

  • Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis
  • The pro‐inflammatory environment in recalcitrant diabetic foot wounds
  • Intra‐lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo …
  • Epidermal growth factor in clinical practice–a review of its biological actions, clinical indications and safety implications
  • Intralesional administration of epidermal growth factor‐based formulation (Heberprot‐P) in chronic diabetic foot ulcer: treatment up to complete wound closure
  • Intralesional injections of Citoprot‐P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation
  • Glucose toxic effects on granulation tissue productive cells: the diabetics’ impaired healing
  • Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds
  • Diabetic foot ulcers and epidermal growth factor: revisiting the local delivery route for a successful outcome
  • Gastrointestinal cell proliferation and crypt fission are separate but complementary means of increasing tissue mass following infusion of epidermal growth factor in rats
  • Diabetic lower extremity wounds: the rationale for growth factors‐based infiltration treatment
  • Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction
  • Cellular senescence as the pathogenic hub of diabetes-related wound chronicity
  • Wound chronicity, impaired immunity and infection in diabetic patients
  • Insulin resistance at the crossroad of Alzheimer disease pathology: A review
  • Potency and stability of C terminal truncated human epidermal growth factor
  • Systemic translation of locally infiltrated epidermal growth factor in diabetic lower extremity wounds
  • Epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) as tissue healing agents: clarifying concerns about their possible role in malignant transformation and …
  • Intestinal growth in parenterally‐fed rats induced by the combined effects of glucagon‐like peptide 2 and epidermal growth factor
  • Medical practice confirms clinical trial results of the use of intralesional human recombinant epidermal growth factor in advanced diabetic foot ulcers

Conclusion

Dr. Jorge Amador Berlanga Acosta exemplifies the qualities of an outstanding researcher through his extensive educational background, significant contributions to science, and recognized leadership. His innovative work on EGF and wound healing positions him as a strong candidate for the Best Researcher Award. By broadening his research scope, enhancing public engagement, and fostering mentorship, he can further elevate his impact on the scientific community and society at large.